A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis

Table 2 Time schedule of the trial

Days	Day 0	Day 1	Day 2	Day 3	Day 7	Day 28
End point	Inclusion			Primary end point		Secondary end point
Antithrombin	30 IU/kg	30 IU/kg	30 IU/kg
Evaluation	A,B,C,D,E	Antithrombin	Antithrombin	A,B,C,E	A,B,C	F
	Antithrombin			Antithrombin	Antithrombin	Mortality

ISSN: 1364-8535